68 related articles for article (PubMed ID: 7892769)
21. Mechanisms of blockade by the novel migraine prophylactic agent, dotarizine, of various brain and peripheral vessel contractility.
Ruiz-Nuño A; Villarroya M; Cano-Abad M; Rosado A; Balfagón G; López MG; García AG
Eur J Pharmacol; 2001 Jan; 411(3):289-99. PubMed ID: 11164387
[TBL] [Abstract][Full Text] [Related]
22. Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze.
Cornélio AM; Nunes-de-Souza RL
Behav Brain Res; 2007 Mar; 178(1):82-9. PubMed ID: 17207863
[TBL] [Abstract][Full Text] [Related]
23. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
[TBL] [Abstract][Full Text] [Related]
24. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
Costall B; Naylor RJ
Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775
[TBL] [Abstract][Full Text] [Related]
25. Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.
Stachowicz K; Gołembiowska K; Sowa M; Nowak G; Chojnacka-Wójcik E; Pilc A
Neuropharmacology; 2007 Nov; 53(6):741-8. PubMed ID: 17870136
[TBL] [Abstract][Full Text] [Related]
26. Effects of the calcium channel blockers Dotarizine and Flunarizine on cerebrovascular reactivity.
Czernicki Z; Jurkiewicz J; Bojanowski K; Piechnik S; Cervos-Navarro J
J Neurol Sci; 1996 Nov; 143(1-2):60-3. PubMed ID: 8981299
[TBL] [Abstract][Full Text] [Related]
27. Interplay between glutamate and serotonin within the dorsal periaqueductal gray modulates anxiety-related behavior of rats exposed to the elevated plus-maze.
Moraes CL; Bertoglio LJ; Carobrez AP
Behav Brain Res; 2008 Dec; 194(2):181-6. PubMed ID: 18675851
[TBL] [Abstract][Full Text] [Related]
28. Some pharmacological properties of new analogs of MP 3022, the 5-HT1A receptor antagonist.
Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E; Paluchowska MH
Pol J Pharmacol; 1999; 51(5):405-13. PubMed ID: 10817541
[TBL] [Abstract][Full Text] [Related]
29. 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat.
Kankaanpää A; Meririnne E; Seppälä T
Psychopharmacology (Berl); 2002 Feb; 159(4):341-50. PubMed ID: 11823886
[TBL] [Abstract][Full Text] [Related]
30. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
31. Behavioral effects of 1-(m-chlorophenyl)piperazine (m-CPP) in a rat model of tardive dyskinesia.
Samad N; Haleem MA; Haleem DJ
Pak J Pharm Sci; 2008 Jul; 21(3):262-8. PubMed ID: 18614422
[TBL] [Abstract][Full Text] [Related]
32. Anxiolytic effects of the aqueous extract of Uncaria rhynchophylla.
Jung JW; Ahn NY; Oh HR; Lee BK; Lee KJ; Kim SY; Cheong JH; Ryu JH
J Ethnopharmacol; 2006 Nov; 108(2):193-7. PubMed ID: 16829000
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and pharmacological evaluation of new arylpiperazines N-[4-[4-(aryl) piperazine-1-yl]-phenyl]-amine derivatives: putative role of 5-HT1A receptors.
Khatri M; Rai SK; Alam S; Vij A; Tiwari M
Bioorg Med Chem; 2009 Mar; 17(5):1890-7. PubMed ID: 19223188
[TBL] [Abstract][Full Text] [Related]
34. Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors.
Peng WH; Wu CR; Chen CS; Chen CF; Leu ZC; Hsieh MT
Life Sci; 2004 Oct; 75(20):2451-62. PubMed ID: 15350820
[TBL] [Abstract][Full Text] [Related]
35. 1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay.
Rajkumar R; Pandey DK; Mahesh R; Radha R
Eur J Pharmacol; 2009 Apr; 608(1-3):32-41. PubMed ID: 19269287
[TBL] [Abstract][Full Text] [Related]
36. Effect of AT II on the exploratory behaviour of rats. Interactions with elymoclavine and bromocryptine.
Petkova B; Georgiev V; Kambourova T
Acta Physiol Pharmacol Bulg; 1991; 17(2-3):84-90. PubMed ID: 1819920
[TBL] [Abstract][Full Text] [Related]
37. In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex.
Iskra-Jopa J; Gołembiowska K; Dziubina A; Cybulski M; Duszyńska B; Chilmonczyk Z
J Pharm Pharmacol; 2005 Feb; 57(2):205-11. PubMed ID: 15720784
[TBL] [Abstract][Full Text] [Related]
38. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E
J Pharm Pharmacol; 2005 Feb; 57(2):253-7. PubMed ID: 15720791
[TBL] [Abstract][Full Text] [Related]
39. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
[TBL] [Abstract][Full Text] [Related]
40. Behavioral and neurochemical profile of m-CPP following exposure to single restraint stress in rat.
Samad N; Haleem DJ
Acta Neurol Belg; 2009 Mar; 109(1):24-31. PubMed ID: 19402569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
